ie-message

Health Economics and Outcomes Research

Enable Real World Evidence (RWE) through evaluation of Real World Data (RWD)

Health Economics and Outcomes Research

What we offer

A wide range of advanced analytical and Health Economics and Outcomes Research (HEOR) consulting services that include effectiveness studies, real world data(RWD) collection, evidence generation and advanced health economic modeling

Who is it for

Medical affairs and HEOR leaders across pharmaceuticals, biotech and medical devices companies

Why it’s important

Demonstrate clinical and economical value of innovations

Close the gap between trial results and real-world outcomes

Enable data-driven decisions based on insights from multiple stakeholder behavior

How we deliver

Process

Our highly experienced team of health economists brings in extensive expertise in RWD modeling, which reduces ambiguities and enables data-driven decisions. We bring together deep domain expertise, mature processes and proprietary NLP/ML clinical and statistical algorithms to generate RWE from primary and secondary real-world patient data.

Our multidisciplinary team of clinicians, medical writers, data scientists, and statisticians enable healthcare enterprises to assess impact of pharmaceutical products on quality of patient life, HCP’s knowledge, and attitude towards them. Our HEOR service portfolio also includes NLP-enabled literature reviews and Meta-Analysis/Network Meta-Analysis for systematic comparative effectiveness studies, clinical trial design, and scientific writing.

How we deliver How we deliver

What makes us different

One-stop solution to a broad range of HEOR services

Global expertise and multi-disciplinary approach

Proprietary AI//ML-based tools to improve speed-to-insights

~400,000

Strong network of physicians, trial sites, ACO/IDN, institutions, health systems, and payer organizations

>100,000,000

Patient records processed

80+

Years of collective HEOR experience with multi-disciplinary team

Resources

Link between a shorter symptom-onset to remdesivir treatment (SORT) interval and mortality in moderate-to-severe COVID-19: A real-world analysis
Feb 2021 Article

Link between a shorter symptom-onset to remdesivir treatment (SORT) interval and mortality in moderate-to-severe COVID-19: A real-world analysis

Metabolic Acidosis in Preterm Infants is Associated with a Longer Length of Stay in the Neonatal Intensive Care Unit
Sep 2020 Article

Metabolic Acidosis in Preterm Infants is Associated with a Longer Length of Stay in the Neonatal Intensive Care Unit

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
Mar 2020 Article

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease

Let's discuss the future of HEOR in your organization

Let's discuss the future of HEOR in your organization